From: The surgical outcomes and risk factors of giant hepatic haemangiomas: a single centre experience
Variable | No morbidity (n = 328) | Morbidity (n = 45) | Univariable analysis | Multivariate analysis | ||
---|---|---|---|---|---|---|
OR (95% CL) | P-value | OR (95% CL) | P-value | |||
Gender (male/female) | 110/218 | 16/29 | 1.223 (0.637–2.145) | 0.920 | ||
Age | 46.32 ± 8.12 | 44.62 ± 8.98 | 1.630 (0.917–2.896) | 0.344 | ||
ASA grading | 1.46 + 0.51 | 1.47 + 0.50 | 1.363 (0.731–2.926) | 0.818 | ||
Number | ||||||
Solitary | 256 (78.0%) | 33 (73.3%) | 1.489 (0.842–2.631) | 0.603 | ||
Multiple | 72 (22.0%) | 12 (26.7%) | ||||
Operative time (min) | 217.56 ± 48.53 | 218.22 ± 53.74 | 1.974 (1.080–3.608) | 0.085 | ||
Operative method | ||||||
Major hepatectomy | 118 (36.0%) | 14 (31.1%) | 1.277 (0.667–2.483) | 0.473 | ||
Minor hepatectomy/enucleation | 210 (64.0%) | 31 (68.9%) | ||||
Blood transfusion | ||||||
No | 222 (67.7%) | 20 (44.4%) | 2.599 (1.409–4.794) | 0.004 | 0.909 (0.455–1.819) | 0.788 |
Yes | 106 (32.3%) | 25 (55.6%) | ||||
Size | ||||||
GH group | 219 (66.8%) | 22 (48.9%) | 2.112 (1.145–3.896) | 0.029 | 2.101 (1.121–3.936) | 0.021 |
EH group | 109 (33.2%) | 23 (51.1%) |